Premium mid-level genetic report services by Prof. Roberto Grobman: Who we are? When we observed the incredible growth of scientific research after the completion of the genome project in 2003. Doctors and other health professionals were unable to update themselves with the millions of articles, results and conclusions published annually. Therefore, this information needed to be catalogued, filtered and transformed in some way to serve as a tool for health professionals. Our Technology experts built a unique AI system that knows to compare results of genetic tests, such as sequencing and genotyping and translate them to useful & focused data for doctors into a variety of 25 different panels The gained knowledge of population characteristics, such as diseases probabilities, physical features, nutrition predisposition, Interacted with AI technology can extract comprehensive details on trends, such as longevity status of populations, medications that better work to individuals or groups, nutrition consuming habits, best sports for each individual, psychological features, etc. This technology can help countries plan the future of their investments in preventive medication for their population. Find even more information at https://www.fulldna.com/.

DNA can tell you everything from your ancestry to pharmacogenomics (‘smart medicine’). For example, we can use DNA testing to help you understand how you metabolise medication: are you a slow or fast metaboliser? Are there certain drugs that might cause an adverse reaction? Pharmacogenetic information could be critically important for someone with a recent diagnosis of a condition such as coronary vascular disease. If you suffer from it, you might have to endure the merry-go-round of trying different drugs to identify the right ones for you. This means delays in receiving the right kind of medication, which can impact costs as well as your recovery.

Entry-level genetic report solutions with Prof. Roberto Grobman today: What are the benefits and risks of direct-to-consumer genetic testing? Direct-to-consumer genetic testing has both benefits and limitations, as they are somewhat different than those of genetic testing ordered by a healthcare provider. Benefits: Direct-to-consumer genetic testing promotes awareness of genetic diseases. It provides personalized information about your health, disease risk, and other traits. It may help you be more proactive about your health. It does not require approval from a healthcare provider or health insurance company.

Genetic testing is on the rise: In recent years, there’s been a dramatic increase in genetic testing. It was nearly unheard of only a few decades ago. Now, you or someone you know has likely had genetic testing within the last year or two. And while healthcare providers can now order far more genetic tests for their patients than in the past, you don’t need a doctor’s order to request this. 23andMe, Ancestry.com, and a number of other testing companies are ready and willing to check your genes for variants associated with certain health conditions, as well as your family ancestry. In fact, spending on direct-to-consumer genetic testing is predicted to reach $2.5 billion within the next few years.

Only once we know it’s been peer reviewed and once we know that an individual can impact their health with easily modifiable environmental changes are we able to say ‘yes, we can bring this to people and help them make use of their DNA to improve their health’. Diagnosis and screening: There are different types of test available. For example, some can diagnose predispositions to certain diseases and/or conditions, for example looking for the BRCA gene — the breast cancer gene. This type of screening can be useful to doctors who might be having a hard time identifying a given disease – especially rare ones.

FullDNA Reports cover specific segments. To reach longevity, FullDNA’s Accurate Prediction Analysis is the most premium tool in the predictive genetics market for health professionals. Knowing in advance the susceptibilities for diseases and health conditions is different than analyzing mutations to find genetics diagnostics. We strongly believe reaching the future in a healthier way. Effective preventive measures can only be adopted when an accurate prediction methodology brings valuable ready to use data. Find more details at Roberto Grobman CTO.